Introduction
Vagal nerve stimulation (VNS) as described in the National Institute of Clinical Excellence (NICE) guidelines on the management of Epilepsy 1 is indicated for use as an adjunctive therapy in reducing the frequency of seizures in children, young adults and adults 2 who are refractory to antiepileptic drug (AED) therapy but who are not suitable for resective surgery. It has been reported to be both effective and safe. The Federal Drug Agency in US has approved its use as a treatment option in patients over the age of 12 who have refractory epilepsy and are not candidates for surgical resection. 3 Montavont and Ryvlin 4 described that the antiepileptic efficacy of VNS in intractable cases was remarkably consistent among their series of patients, with an average decrease in seizure frequency of 40%. They suggested a 50% responder rate (i.e. the proportion of patients whose seizure frequency declined by at least 50%) and a proportion of seizure-free patients below 5%. VNS involves a small operation to implant under the skin a generator. This is usually below the left collar with its coils wrapped around the left Vagus at the side of the neck under the skin.
Parasympathetic innervations of the heart are controlled by the Vagus nerve. The Vagus nerve when stimulated acts to lower the heart rate. The right Vagus innervates the Sinoatrial (SA) node and when there is parasympathetic hyper stimulation it predisposes those affected to bradyarrhythmias. The left Vagus innervates the atrioventricular (AV) node and when hyper stimulated predisposes the heart to AV blocks.
VNS is generally well tolerated and safe, but there have been cases reported of bradycardia occurring intraoperatively and clinically. 5, 6 We came across a few reports, one of which described a delayed intractable bradycardia resulting from a Vagus nerve under traction by tethered stimulator leads 7 and three other case reports of late onset cardiac arrhythmia post VNS, one occurring in a 17 year old young man 2 years and 4 months post VNS, 8 another occurring in a 13 year old boy 6 and a half years post VNS 9 and the last occurring in a 47 year old woman 9 years post VNS. 10 None of these cases were reported to have an intellectual disability. We report a case of a 55 year old man with intellectual disability who about 8 years later developed an iatrogenic ventricular asystole presenting as recurrent cardiogenic syncope following VNS which was initially misdiagnosed as his seizure worsening.
Case report
This is a case of a 55 year old man with intellectual disability and partial seizure with secondary generalisation as well as drop attacks (atonic seizures), secondary to a cerebral anoxic brain damage during his perinatal period. He was managed on a variety of AED treatments over the years and his epilepsy was eventually assessed as being refractory to AED treatment. He was then offered a VNS in 2003. His AED's at the time included Levetiracetam 3000 mg/day and Oxcarbazepine 1200 mg/day and his seizure frequency was averaging about 70 per month inclusive of both seizure types.
His VNS workup did not reveal any cardiac problems. His VNS was fitted following usual procedures. The required intraoperative tests were performed and no complications were noted. Following his VNS being fitted his seizure frequency and intensity of both seizure types improved significantly. Approximately 8 years later there was an increase in what seemed to be atonic seizures which started occurring on an almost daily basis, which given his history were considered to be his seizure worsening. The AED treatment he was on at the time which included Levetiracetam 3000 mg/day and Pregabalin 300 mg/day were adjusted and his VNS was checked and titrated but there was no improvement in his seizures. A detailed description of these events suggested that these attacks were different from previous episodes and pointed at a cardiac cause. An assessment of his cardiac status was then requested. No electroencephalogram (EEG) was done to rule out the seizures as interictal activity causing bradycardia or asystole.
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During review by his cardiologist he described an awareness of his VNS firing during which he developed feelings of lethargy and pre-syncope which was occasionally followed by a loss of consciousness for up to 2 min at a time. Initial physical examination was normal. His pulse rate was 70 beats/min but this fell to 40 beats/min during an observed episode when his VNS fired. His blood pressure was 146/98, with postural drop within 3 min of standing. Subsequent electrocardiogram (ECG) showed sinus rhythm and was within normal limits.
There was a suspicion that the VNS was causing symptomatic bradycardia and a 24 h cardiac monitor was arranged. This showed recurrent episodes of ventricular standstills, pauses ( Fig. 1) and runs of complete heart block, the longest duration being 12.7 s. During the bradycardia episodes and ventricular standstill the VNS electrical impulses were clearly seen on the cardiac tracing. Normal P wave activity continued during the episodes of bradycardia, although at a slightly slower rate than the baseline rate before the VNS was firing. VNS setting output was 2.25 milliamp (mA), frequency 20 H, pulse width 250 ms, 30 s on and 3 min off time.
At this point the VNS was deactivated, following discussion with patient, his family and carers. A repeat 24 h cardiac monitor was arranged, which showed this time around sinus rhythm throughout. The only abnormality seen during this period of monitoring was first degree heart block, with a PR interval of 220 ms.
Approximately 2 months after the VNS was deactivated his secondary generalised seizures worsened despite efforts to optimise his AED treatment. Following another discussion with the patient, his family and carers a decision was made to reactivate his VNS again. This occurred 4 months after it was initially deactivated. The VNS was turned on at an output of 0.25 mA (7 s on time) and increased gradually by 0.25 mA every 3-4 days. At 1 mA our patient unfortunately sustained recurrent syncope. A repeat 24 h cardiac monitoring showed significant pauses of up to 9.79 s (Fig. 2) . Although the VNS output impulses were of much smaller amplitude, they were still clearly visible on the cardiac trace and correlated with every episode of bradycardia or ventricular standstill. The cardiac monitoring also showed continued P wave activities but there were runs of ventricular asystole.
A consensus decision was made and the VNS was again deactivated. Following discussion with his cardiologist, he was offered the option of either a pacemaker insertion, followed by VNS reactivation, or an increase in his AED therapy with the VNS remaining deactivated. The patient opted for the latter. A 24 h EEG was done after the VNS was deactivated the second time and showed temporal sharp waves with right sided emphasis suggesting epileptic activity. There were no typical drop attacks captured during the recording.
Discussion
The reason for the ventricular asystole in our patient remains at best obscured or speculative. Our patient had no prior history of cardiac problems, his generator had been monitored at regular intervals and the setting had not been changed in the months before the recurrent syncope, no generator malfunction had been detected and there had been no major changes in his AED treatment such as the commencement of a new medication.
Asconapé et al. 6 described a case report of intraoperative bradycardia and asystole and highlighted a number of possible causes for their observation some of which included the placement of the electrodes, aberrant anatomy and collateral stimulation of the cervical cardiac nerves. If any of these were present in our patient they should have occurred earlier during VNS treatment. Amark et al. 8 in a case report of a young man developing bradyarrhythmia 2 years after VNS implantation could not identify a specific cause for their observation. It is our view that the ventricular asystole noted in our patient was iatrogenic which like in our patient can be misdiagnosed as a case of seizure worsening. This is especially an issue of concern in vulnerable adults such as our patient who might have intellectual disability and limited mechanisms of communication to express their distress or provide relevant history or symptomology. As far as we are aware there are only two other reports of ventricular asystole occurring so late in VNS therapy. 9, 10 Although VNS is considered a safe option in refractory epilepsy management it is important that clinicians should be aware of this rare but late onset, potentially life threatening adverse effect of VNS. It is our view that given the higher incidence of sudden death in patients with refractory epilepsy, 12 regular monitoring of cardiac status might be called for in VNS fitted patients especially if there is a worsening in certain types. Fig. 1 . AV blocking on 24 h ECG prior to 1st VNS deactivation.
